Wasim Dar, MD
Transplant Surgery · Hartford, CTNPI 1477501039
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $4,145 of the $5,703 with a category attached, or 72.7%. 15 manufacturers reported payments, led by Organox Ltd at 57.9% of the total. Reporting peaked in 2019 at $1,623 and has fallen 82.4% since, to $286 in 2025.
Across 32 payments — averaging $178.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organox Ltd$3K
- Baxter Healthcare$573
- Intuitive Surgical$375
- Veloxis Pharmaceuticals, Inc.$349
- Covidien LP$325
- Dilon Technologies, Inc.$166
- plus $615 from 9 others
What the payments were for
- Consulting fees$4,14573%
- Travel & lodging$3757%
- Food & beverage$1,18321%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organox Ltd | 3 | $3,300 |
| Baxter Healthcare | 4 | $573 |
| Intuitive Surgical | 2 | $375 |
| Veloxis Pharmaceuticals, Inc. | 11 | $349 |
| Covidien LP | 1 | $325 |
| Dilon Technologies, Inc. | 1 | $166 |
| Stryker | 1 | $141 |
| Gilead | 1 | $127 |
| Dynavax Technologies Corporation | 1 | $123 |
| Eisai Inc. | 1 | $93 |
| Sanofi-aventis U.S. LLC | 2 | $42 |
| Acell, Inc. | 1 | $34 |
| Novartis | 1 | $21 |
| Merck | 1 | $19 |
| Mallinckrodt Hospital Products Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TISSEEL$520
- Da Vinci Surgical System$356
- HemoBlast Bellows$166
- SPY-PHI SYSTEM$141
- Livdelzi$127
- Envarsus$124
- Heplisav-B$123
How this compares
Too few transplant surgery providers in Connecticutto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amlodipine Besylate | 14 | $21 |
Paid to pharmacies, not to this prescriber.
Other transplant surgery in Hartford
- Oscar SerranoHartford$6K
- Anne LallyHartford$4K
- Glyn MorganHartford$1K
- Patricia SheinerHartford$1K
- Sanjay KulkarniNew Haven$2K
- Gregory AziaNew London$387
- Joohyun KimNew Haven$227
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.